[go: up one dir, main page]

Byrne et al., 2000 - Google Patents

Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density

Byrne et al., 2000

View PDF
Document ID
11968412703837985753
Author
Byrne C
Colditz G
Willett W
Speizer F
Pollak M
Hankinson S
Publication year
Publication venue
Cancer research

External Links

Snippet

Insulin-like growth factors (IGFs) and insulin-like growth factor-binding proteins (IGFBPs) play a role in the normal development of breast tissue and possibly in the etiology of breast cancer. Breast density is one of the strongest predictors of breast cancer. In a cross-sectional …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10—Services
    • G06Q50/22—Health care, e.g. hospitals; Social work

Similar Documents

Publication Publication Date Title
Byrne et al. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density
Bhasin et al. Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline
Tamimi et al. Endogenous sex hormone levels and mammographic density among postmenopausal women
Greendale et al. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study
Tamimi et al. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women
Hankinson et al. Circulating concentrations of insulin-like growth factor I and risk of breast cancer
Zeleniuch-Jacquotte et al. Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study
Parker et al. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses’ health study
Diorio et al. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density
Boyd et al. The association of breast mitogens with mammographic densities
Lippman et al. Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants
Cummings et al. Serum estradiol level and risk of breast cancer during treatment with raloxifene
Baglietto et al. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer
Lukanova et al. Prediagnostic levels of C‐peptide, IGF‐I, IGFBP‐1,‐2 and‐3 and risk of endometrial cancer
Ziv et al. Mammographic density and estrogen receptor status of breast cancer
Legro et al. Rapid maturation of the reproductive axis during perimenarche independent of body composition
Sowers et al. Follicle stimulating hormone and its rate of change in defining menopause transition stages
Friedrich et al. Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP)
Hui et al. Bone loss at the femoral neck in premenopausal white women: effects of weight change and sex-hormone levels
Devine et al. Prediction of incident osteoporotic fractures in elderly women using the free estradiol index
Greendale et al. Serum prolactin levels are positively associated with mammographic density in postmenopausal women
Pacholczak et al. Associations of anthropometric measures on breast cancer risk in pre-and postmenopausal women—a case-control study
Endogenous Hormones and Breast Cancer Collaborative Group Free estradiol and breast cancer risk in postmenopausal women: comparison of measured and calculated values
Khan et al. The normal breast epithelium of women with breast cancer displays an aberrant response to estradiol
Gertig et al. Association of age and reproductive factors with benign breast tissue composition